Tekla Capital Management LLC Galapagos Nv Transaction History

Tekla Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$96.85 - $148.25 $633,689 - $969,999	-6,543 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$146.12 - $215.82 $379,619 - $560,700	-2,598 Reduced 28.42%	6,543 $1.35 Million
Q3 2019 Nov 13, 2019	SELL	$130.44 - $187.64 $5.14 Million - $7.39 Million	-39,384 Reduced 81.16%	9,141 $1.4 Million
Q1 2019 May 14, 2019	SELL	$89.61 - $117.78 $4.6 Million - $6.04 Million	-51,290 Reduced 51.39%	48,525 $5.72 Million
Q3 2018 Nov 13, 2018	BUY	$90.63 - $120.22 $1.18 Million - $1.56 Million	13,000 Added 14.97%	99,815 $11.2 Million
Q2 2018 Aug 13, 2018	SELL	$88.4 - $105.34 $779,688 - $929,098	-8,820 Reduced 9.22%	86,815 $8 Million
Q1 2018 May 14, 2018	BUY	$94.51 - $120.23 $4.01 Million - $5.1 Million	42,435 Added 79.77%	95,635 $9.54 Million
Q4 2017 Feb 14, 2018	BUY	$84.48 - $104.02 $2.89 Million - $3.56 Million	34,200 Added 180.0%	53,200 $4.99 Million
Q2 2017 Aug 14, 2017	BUY	N/A	19,000	19,000 $1.45 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.